UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.
Annabelle Lee’s diagnosis of a ortopulmonary window and pulmonary stenosis was just the beginning of her heart challenges. A secondary diagnosis of supravalvular aortic stenosis meant a new mission for the family.
UC San Diego Health has been recognized as a top performer in the 2022 Quality Leadership Ranking by Vizient, Inc. This is the fourth consecutive year that UC San Diego Health has been ranked among the top ten academic health systems in the United States.